DPP4 has been shown to be significantly upregulated in various proinflammatory conditions including obesity, diabetes, thrombosis, and atherosclerotic vascular diseases [16, 17, 18, 19, 20]. Here, DPP4 is linked to obesity due to melanocortin 4 receptor deficiency.